The synthesis and evaluation of cyclic ureas as HIV protease inhibitors:: Modifications of the P1/P1′ residues

被引：29
|
作者：
Patel, M
Bacheler, LT
Rayner, MM
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Seitz, SP
机构：
[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Virol, Wilmington, DE 19880 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 07期
关键词：
D O I：
10.1016/S0960-894X(98)00119-X
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two series of cyclic ureas modified at the P1/P1' residue were prepared and evaluated for HIV protease inhibition and whole cell antiviral activity. Compounds 8b, 10 (3- and 4-pyridylmethyl analogs) and 6b (4-methoxy analog) showed significant improvement in antiviral activity relative to lead compounds DMP323 and DMP 450. (C) 1998 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：823 / 828
页数：6
相关论文
共 50 条
  • [1] The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors
    Patel, M
    Kaltenbach, RF
    Nugiel, DA
    McHugh, RJ
    Jadhav, PK
    Bacheler, LT
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Garber, S
    Reid, C
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (09) : 1077 - 1082
  • [2] The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P-1/P-1' residues
    Patel, M
    Seitz, SP
    Bacheler, LT
    Rayner, MM
    Cordova, BC
    Meek, JL
    EricksonViitanen, S
    Han, Q
    Lam, PYS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 23 - MEDI
  • [3] Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents
    Kaltenbach, RF
    Klabe, RM
    Cordova, BC
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (15) : 2259 - 2262
  • [4] Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors
    Kaltenbach, RF
    Patel, M
    Waltermire, RE
    Harris, GD
    Stone, BRP
    Klabe, RM
    Garber, S
    Bacheler, LT
    Cordova, BC
    Logue, K
    Wright, MR
    Erickson-Viitanen, S
    Trainor, GL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 605 - 608
  • [5] Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2′ to P1/P1′
    Ax, A
    Schaal, W
    Vrang, L
    Samuelsson, B
    Hallberg, A
    Karlén, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (03) : 755 - 764
  • [6] Novel inhibitors of HIV protease: Design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds
    Spaltenstein, A
    Almond, MR
    Bock, WJ
    Cleary, DG
    Furfine, ES
    Hazen, RJ
    Kazmierski, WM
    Salituro, FG
    Tung, RD
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1159 - 1162
  • [7] Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors
    Huang, PP
    Randolph, JT
    Klein, LL
    Vasavanonda, S
    Dekhtyar, T
    Stoll, VS
    Kempf, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4075 - 4078
  • [8] Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: Synthesis, structure-activity relationship, and x-ray crystal structure analysis
    Nugiel, DA
    Jacobs, K
    Cornelius, L
    Chang, CH
    Jadhav, PK
    Holler, ER
    Klabe, RM
    Bacheler, LT
    Cordova, B
    Garber, S
    Reid, C
    Logue, KA
    GoreyFeret, LJ
    Lam, GN
    EricksonViitanen, S
    Seitz, SP
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) : 1465 - 1474
  • [9] P1/P1′-modified benzothiadiazepines as metalloproteinase inhibitors.
    Cherney, RJ
    Maeyer, DT
    Wang, L
    Duan, JJW
    Chen, LH
    Arner, EC
    Jaffe, BD
    Covington, MB
    Decicco, CP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U940 - U940
  • [10] Structure-based design, synthesis, evaluation and x-ray crystal structure analysis of HIV-1 protease inhibitors with modified P1, P1′ and P2′ groups
    Rusere, Linah
    Ali, Akbar
    Lockbaum, Gordon
    Lee, Sook-Kyung
    Swanstrom, Ronald
    Schiffer, Celia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
12345